title: Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.
abstract: Human immunodeficiency virus type 1 (HIV-1) replication efficiency or fitness, as measured in cell culture, has been postulated to correlate with clinical outcome of HIV infection, although this is still controversial. One limitation is the lack of high-throughput assays that can measure replication efficiency over multiple rounds of replication. We have developed a multiple-cycle growth competition assay to measure HIV-1 replication efficiency that uses flow cytometry to determine the relative proportions of test and reference viruses, each of which expresses a different reporter gene in place of nef. The reporter genes are expressed on the surface of infected cells and are detected by commercially available fluorescence-labeled antibodies. This method is less labor-intensive than those that require isolation and amplification of nucleic acids. The two reporter gene products are detected with similar specificity and sensitivity, and the proportion of infected cells in culture correlates with the amount of viral p24 antigen produced in the culture supernatant. HIV replication efficiencies of six different drug-resistant site-directed mutants were reproducibly quantified and were similar to those obtained with a growth competition assay in which the relative proportion of each variant was measured by sequence analysis, indicating that recombination between the pol and reporter genes was negligible. This assay also reproducibly quantified the relative fitness conferred by protease and reverse transcriptase sequences containing multiple drug resistance mutations, amplified from patient plasma. This flow cytometry-based growth competition assay offers advantages over current assays for HIV replication efficiency and should prove useful for the evaluation of patient samples in clinical trials.
authors.affiliation: Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
authors.forename: Carrie
authors.initials: C
authors.lastname: Dykes
authors.forename: Jiong
authors.initials: J
authors.lastname: Wang
authors.forename: Xia
authors.initials: X
authors.lastname: Jin
authors.forename: Vicente
authors.initials: V
authors.lastname: Planelles
authors.forename: Dong Sung
authors.initials: DS
authors.lastname: An
authors.forename: Amanda
authors.initials: A
authors.lastname: Tallo
authors.forename: Yangxin
authors.initials: Y
authors.lastname: Huang
authors.forename: Hulin
authors.initials: H
authors.lastname: Wu
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Demeter
mesh_terms: D000818:Animals; D002460:Cell Line; D005434:Flow Cytometry / Q000379:methods*; D017930:Genes, Reporter; D016655:HIV Core Protein p24 / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D006801:Humans; D051379:Mice; D009154:Mutation; D011995:Recombination, Genetic; D012680:Sensitivity and Specificity; D018800:Thy-1 Antigens / Q000235:genetics / Q000378:metabolism; D014776:Virus Cultivation; D014779:Virus Replication
chemical_list: D016655:HIV Core Protein p24; D018800:Thy-1 Antigens